Akari Therapeutics (AKTX) vs Lipocine (LPCN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lipocine (LPCN) has outperformed Akari Therapeutics (AKTX) over the past year, losing 31.7% versus a loss of 79.5%. Over five years, LPCN leads with a -88.5% price change compared with -99.3% for AKTX. Akari Therapeutics is the larger company by market cap ($19.3 million vs $16.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKTX | LPCN |
|---|---|---|
| Share price | $8.44 | $1.96 |
| Market cap | $19.29M | $16.15M |
| 1-day change | -2.14% | -10.98% |
| YTD return | -25.39% | -72.60% |
| 1-year return | -79.46% | -31.68% |
| 5-year return | -99.35% | -88.55% |
| EPS (TTM) | $0.00 | $-1.85 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.80 | $12.37 |
| 52-week low | $3.02 | $1.81 |
| Distance from 52-week high | -80.28% | -84.16% |
| Average volume | 60.35K | 1.68M |
| Shares outstanding | 2.29M | 8.24M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LPCN has outperformed AKTX by 47.8 percentage points over the past year.
AKTX vs LPCN FAQ
Which is bigger, Akari Therapeutics or Lipocine?
Akari Therapeutics (AKTX) is larger, with a market capitalization of $19.29M compared with $16.15M for Lipocine (LPCN).
Which stock has performed better over the past year, AKTX or LPCN?
LPCN returned -31.68% over the past 12 months, compared with -79.46% for AKTX (price return, excluding dividends). Past performance does not predict future results.
Are Akari Therapeutics and Lipocine in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.